Showing results (731-740 of 1,072) with videos related to

Sort By:
Pageof 108
Medcomm|June 8, 2026
Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell TransplantationXiao-Di Ma, Jie Ji, Zheng-Li Xu, et al.
Cancer Letters|July 10, 2026
Impact of Concurrent Genetic Alterations on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic SyndromesYao Sun, Jing Liu, Jia Chen, et al.
Chinese Medical Journal|September 8, 2010
Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation: a prospective multi-center trialKai-yan Liu, Yu Wang, Ming-zhe Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 3, 2004
[Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia]Huan Chen, Han-yun Ren, Nai-lan Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 1, 2013
[Outcome of haploidentical hematopoietic stem cell transplantation for refractory/relapsed acute leukemia]Yu Wang, Dai-hong Liu, Kai-yan Liu, et al.
Zhonghua Nei Ke Za Zhi|August 24, 2013
[The risk factors and prognosis of transplant-associated thrombotic microangiopathy following acute graft-versus-host disease]Xiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, et al.
American Journal of Hematology|March 29, 2013
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantationXiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 28, 2008
[PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease]Ya-zhen Qin, Jin-lan Li, Hong-hu Zhu, et al.
Zhonghua Yi Xue Za Zhi|July 26, 2007
[Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation]Yao Chen, Lan-ping Xu, Dai-hong Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2017
IFN-α Is Effective for Treatment of Minimal Residual Disease in Patients with Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Registry StudyXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Pageof 108